Worldwide Study Finder

Loading registry information…

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:32 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableUnknownINTERVENTIONAL

Effects of Intramural Fibroids on IVF Outcome

ClinicalTrials.gov · NCT03904355 · Registry updated: 2021-08-31

Condition / research focus: Infertility, Female; Assisted Reproduction
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-05-01. Completion: 2022-05 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonadotropins (drug) — also listed as: Ovarian stimulation
human chorionic gonadotropin (drug) — also listed as: Triggering of ovulation
Ovum pick up (procedure)
Embryo transfer (procedure)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Cairo, Egypt

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Phase 3CompletedINTERVENTIONAL

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique

ClinicalTrials.gov · NCT01297465 · Registry updated: 2021-05-28

Condition / research focus: Assisted Reproductive Techniques; Reproductive Technology, Assisted
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Denmark · Finland · France · Germany · Greece · Italy · Netherlands · Poland · Russia · Slovakia · United Kingdom
Registry dates and results: Start: 2011-05-31. Completion: 2012-10-31 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonal-f® (drug) — also listed as: Follitropin alfa
Pergoveris® (drug)
Pergoveris® (drug)
Recombinant human chorionic gonadotropin (r-hCG) (drug) — also listed as: Ovidrel®, Ovitrelle®

Where the study takes place — 23 listed sites

Research Site
Dronninglund, Denmark
Site recruitment: Not reported
Research Site
Fredericia, Denmark
Site recruitment: Not reported
Research Site
Helsinki, Finland
Site recruitment: Not reported
Research Site
Bondy, France
Site recruitment: Not reported
Research Site
Bruges, France
Site recruitment: Not reported
Research Site
Clamart, France
Site recruitment: Not reported
Research Site
Thenon, France
Site recruitment: Not reported
Research Site
Villeurbanne, France
Site recruitment: Not reported
Research Site
Berlin, Germany
Site recruitment: Not reported
Research Site
Halle, Germany
Site recruitment: Not reported
Research Site
Heraklion, Crete, Greece
Site recruitment: Not reported
Research Site
Pylaia, Thessaloniki, Greece
Site recruitment: Not reported
Research Site
Athens, Greece
Site recruitment: Not reported
Research Site
Bologna, Italy
Site recruitment: Not reported
Research Site
Florence, Italy
Site recruitment: Not reported
Research Site
Torino, Italy
Site recruitment: Not reported
Research Site
Zwolle, Netherlands
Site recruitment: Not reported
Research Site
Warsaw, Poland
Site recruitment: Not reported
Research Site
Moscow, Russia
Site recruitment: Not reported
Research Site
Samara, Russia
Site recruitment: Not reported
Research Site
Bratislava, Slovakia
Site recruitment: Not reported
Research Site
London, United Kingdom
Site recruitment: Not reported
Research Site
Swansea, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Worldwide Study Finder

Worldwide Study Finder

Find a study

Registry search results

Effects of Intramural Fibroids on IVF Outcome

Explore the world’s study registries

Worldwide

Africa

Americas

Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique

Evaluation of a Mobile Preconception Lifestyle Programme in Couples Undergoing In Vitro Fertilisation

Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate Resistance

The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome

Low-dose HCG as an Adjunct to Ovarian Stimulation in Subfertile Women Undergoing ART

Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation

Comparative Bioavailability Study of Human Chorionic Gonadotropin (hCG)-IBSA Versus a Marketed hCG Formulation

Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin

Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG

A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve

Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations

The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients

A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

Effect of Adding Isoflavonoids to Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Syndrome

Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI

Biosimilarity Study of IM Injection of Human Chorionic Gonadotrophin After Parenteral Administration of Treatment A TEST Product Epifasi 5000 I.U. Ampoules (EIPICO PHARMA, EGYPT) and Treatment B REFERENCE Product Pregnyl 5000 I.U. Ampoules (Baxter Pharmaceutical Solutions for Organon, USA).

The Effect of Granulocyte Colony Stimulating Factor Versus Human Chorionic Gonadotropin in Females With a History of RIF

ICSI Versus Conventional IVF in Non-male Factor Couples

Asia

Middle East

Europe

Oceania